CN105726574A - 玳瑁胶的制备及应用 - Google Patents
玳瑁胶的制备及应用 Download PDFInfo
- Publication number
- CN105726574A CN105726574A CN201610199235.7A CN201610199235A CN105726574A CN 105726574 A CN105726574 A CN 105726574A CN 201610199235 A CN201610199235 A CN 201610199235A CN 105726574 A CN105726574 A CN 105726574A
- Authority
- CN
- China
- Prior art keywords
- eretmochelys
- imbricate
- linnaeus
- carapax eretmochelydis
- glue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 241001125672 Eretmochelys Species 0.000 title abstract description 11
- 239000000084 colloidal system Substances 0.000 title abstract description 10
- 235000021419 vinegar Nutrition 0.000 claims abstract description 18
- 239000000052 vinegar Substances 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 14
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims abstract description 7
- 206010022437 insomnia Diseases 0.000 claims abstract description 7
- 206010007247 Carbuncle Diseases 0.000 claims abstract description 5
- 206010010904 Convulsion Diseases 0.000 claims abstract description 5
- 206010012218 Delirium Diseases 0.000 claims abstract description 5
- 206010025421 Macule Diseases 0.000 claims abstract description 5
- 230000036461 convulsion Effects 0.000 claims abstract description 5
- 230000000694 effects Effects 0.000 claims abstract description 5
- 208000024891 symptom Diseases 0.000 claims abstract description 5
- 230000002936 tranquilizing effect Effects 0.000 claims abstract description 5
- 206010010071 Coma Diseases 0.000 claims abstract description 3
- 239000003292 glue Substances 0.000 claims description 28
- 239000003814 drug Substances 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 10
- 239000004576 sand Substances 0.000 claims description 9
- 239000012567 medical material Substances 0.000 claims description 8
- 231100000614 poison Toxicity 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 239000003440 toxic substance Substances 0.000 claims description 5
- 206010026749 Mania Diseases 0.000 claims description 4
- 208000007101 Muscle Cramp Diseases 0.000 claims description 4
- 208000005392 Spasm Diseases 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 4
- 235000009508 confectionery Nutrition 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 230000007794 irritation Effects 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 239000008158 vegetable oil Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 229920000297 Rayon Polymers 0.000 claims description 2
- 208000003443 Unconsciousness Diseases 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- 238000009833 condensation Methods 0.000 claims description 2
- 230000005494 condensation Effects 0.000 claims description 2
- 150000002333 glycines Chemical class 0.000 claims description 2
- 208000021760 high fever Diseases 0.000 claims description 2
- 206010025482 malaise Diseases 0.000 claims description 2
- 229910052573 porcelain Inorganic materials 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 235000000346 sugar Nutrition 0.000 claims description 2
- 238000000605 extraction Methods 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 241001366512 Agrypnia Species 0.000 abstract 1
- 208000025599 Heat Stress disease Diseases 0.000 abstract 1
- 206010068188 Heat illness Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000007670 refining Methods 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 7
- 239000000523 sample Substances 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 210000000582 semen Anatomy 0.000 description 5
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- 239000004471 Glycine Substances 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000209094 Oryza Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 235000021551 crystal sugar Nutrition 0.000 description 3
- 229960003067 cystine Drugs 0.000 description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 229930182817 methionine Natural products 0.000 description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 235000004400 serine Nutrition 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 241001550206 Colla Species 0.000 description 2
- 241000209020 Cornus Species 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 235000008521 threonine Nutrition 0.000 description 2
- OIXLLKLZKCBCPS-RZVRUWJTSA-N (2s)-2-azanyl-5-[bis(azanyl)methylideneamino]pentanoic acid Chemical compound OC(=O)[C@@H](N)CCCNC(N)=N.OC(=O)[C@@H](N)CCCNC(N)=N OIXLLKLZKCBCPS-RZVRUWJTSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000270605 Chelonia Species 0.000 description 1
- 241000270617 Cheloniidae Species 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 241001125671 Eretmochelys imbricata Species 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 241000270711 Malaclemys terrapin Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000337007 Oceania Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007803 cold maceration Methods 0.000 description 1
- 108010052008 colla corii asini Proteins 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种玳瑁药材的炮制工艺,得到醋制玳瑁,能够明显提高玳瑁的有效成分提取率。本发明还公开了玳瑁胶的制备工艺,玳瑁胶具有和玳瑁相似的功效及应用范围,玳瑁胶便于携带便于服用。玳瑁经醋制及制成玳瑁胶后具有清热解毒、镇心安神的功效,可用于热病神昏、谵语惊狂、惊风抽搐、痈肿疮毒、斑疹症。玳瑁胶还可以制成保健品,用于改善或辅助改善心神不宁引起的失眠、多梦、不寐症状。本发明所用玳瑁为人工饲养品种。
Description
技术领域
本发明涉及玳瑁胶的制备及其应用,并公开玳瑁胶的制备方法,属于中药及中药制剂领域。
背景技术
玳瑁(EretmochelysimbricateLinnaeus)来源于龟鳖目Testudinata,潜颈龟亚目Cryptodira海龟科Cheloniidae玳瑁属Eretmochelys,背甲共有13块,作覆瓦状排列,所以又称十三鳞,古名瑇瑁,文甲等,中医药临床用其甲,具有清热解毒、镇心安神之功,可用于热病神昏、谵语惊狂、惊风抽搐、痈肿疮毒、斑疹等。早在唐代《本草拾遗》中就有记载,《本草纲目》谓:“玳瑁解毒清热之功同于犀角”,《圣惠方》载玳瑁丸,“治急风及中恶,不识人,面青,四肢逆冷”,《圣济总录》中玳瑁丸则“用于治疗中风不语,精神冒闷及中恶不语”。临床应用以生用为主,亦有炮制使用,炮制以蒸后镑极薄片及丝为主,《圣惠方》等文献中载有滑石粉制玳瑁的应用。临床研究发现玳瑁及其配方制剂能够改善癌症发热,还可用于免疫系统疾病、肺损伤等,临床应用多种药理活性。玳瑁甲片含有角蛋白、胶质、微量元素等,其体内所含的氨基酸种类和数量均较陆生龟鳖类高。
胶剂是指用动物皮、骨、甲、角等为原料,用水煎取胶质,浓缩成干胶状的内服制剂,其主要成分是动物水解蛋白类物质,并根据原料的特点加入一定量的冰糖、植物油、黄酒等辅料。目前,中医药临床使用的胶剂有阿胶、鹿角胶、龟甲胶、龟鹿二仙胶等。胶剂多以烊化内服为主,一般具有补益作用。中药玳瑁临床应用炮制品以净制、切制为主,偶有滑石粉制用。另外,玳瑁为国家二级保护动物,野生资源受国家保护,禁止捕捞使用。玳瑁分布范围较广,加勒比海地区、大洋洲海域、非洲海岸、印度洋海域等均有分布,中国从山东南部海域到南海诸岛海域均有分布,广东省及海南省部分地区有养殖,江苏、浙江、福建等沿海地区亦适合养殖,因此本发明所用玳瑁药材均来源于养殖品。
发明内容
本发明提供了一种新的玳瑁炮制工艺,得到醋制玳瑁,具体工艺如下。
本发明炮制工艺:取净河砂(过3号标准筛)120~180g,置炒药锅中翻炒至灵活状态、颜色加深,投入大小分档的玳瑁药材40~60g,翻炒至玳瑁甲片鼓起、有焦斑、酥脆、并有一定的甲焦臭味散出,起锅,筛去河砂,趁热投入米醋中,浸渍5~10分钟,捞出,控去醋液,30~70℃烘干。炒制过程中炉温控制在100~180℃,醋制时所用米醋量以能没过药材为度。
本发明提供了一种玳瑁胶剂的制备方法及工艺,制得玳瑁胶,其工艺如下。
本发明玳瑁胶的制备:玳瑁药材,打碎成大小均匀的块,洗净,取100g,加水2000~4000mL,常压,或加压1.2~1.6Mpa,温度100~110℃,煎煮5~24个小时,趁热过滤,滤渣如前述条件继续煎煮2~3次,合并滤液,加明矾0~0.1g,搅拌均匀,静置5~10个小时,滤取胶液。浓缩,待胶液浓缩去大部分水分后呈粘稠状态,加入豆油1~5ml,边加边搅拌至均匀无油泡。继续浓缩汁稠厚状态加入冰糖粉5~10g,黄酒5~10g,搅拌均匀,继续浓缩至胶液有气泡鼓起,挑起成片状或线状坠落,停止加热,趁热倒入事先涂抹植物油的瓷盘中,自然冷凝24~48个小时至成固体胶块,取出,切片,得玳瑁胶。玳瑁胶携带方便,服用方便,开水烊化服用即可。
本分明进一步提供玳瑁胶在中医药学上的应用,玳瑁胶在清热解毒、镇心安神功效上的应用,玳瑁胶可以用于高热神昏、谵语惊狂、惊风抽搐、痈肿疮毒、斑疹症。
本发明进一步提供玳瑁胶在保健品上的应用,玳瑁胶及含有玳瑁胶的糕点、糖果、饮品、保健品可以用于改善或辅助改善心神不宁等引起的失眠、不寐等症状。
具体实施方式
实施例1以70%的乙醇为溶剂按《中国药典》2015年版四部2201浸出物测定法项下热浸法测定不同炮制方法对玳瑁浸出物的影响,结果如下表所示。
玳瑁炮制品 | 生品 | 砂烫 | 蛤粉炒 | 滑石粉炒 | 砂烫醋淬 | 蛤粉炒醋淬 |
浸出物(%) | 7.34 | 10.16 | 10.36 | 8.62 | 18.89 | 12.16 |
炮制是根据中医药理论结合临床对中药进行的一系列加工处理,炮制可以使中药增效减毒、可以矫嗅矫味、利于有效成分的溶出。本实验通过对玳瑁浸出物的测定考察了炮制对玳瑁的影响,发现炮制后浸出物的量明显提高,加液体辅料米醋可以明显提高浸出物的量,其中砂烫醋淬后浸出物的量显著高于生品。对浸提方法的考察则发现热浸法较冷浸法可以得到更高的提取率。另外,炮制后玳瑁原有的腥臭味减失,更易于粉碎。
结论:通过浸出物的测定发现砂烫醋淬可以明显提高浸出物的量,以此为依据的话,砂烫醋淬为最佳提取工艺。
实施例2氨基酸的测定氨基酸测定色谱条件:洗脱泵流速0.45mL·min-1,衍生泵流速0.25mL·min-1,检测波长570nm、440nm,柱温58~74℃,反应器温度130℃,进样量50μl,流动相A为0.12N柠檬酸钠缓冲液(pH3.5)、流动相B为0.2N柠檬酸钠缓冲液(pH10.85)、流动相C为5%的甲醇水溶液用于检测后清洗色谱柱及仪器、流动相D为再生液、流动相配比如下表所示。
时间(min) | A% | B% | D% |
0.00~3.50 | 100 | 0 | 0 |
11.00 | 85 | 15 | 0 |
17.00 | 80 | 20 | 0 |
23.00 | 67 | 33 | 0 |
27.00~30.00 | 45 | 55 | 0 |
31.00~43.00 | 0 | 100 | 0 |
43.10~46.00 | 0 | 0 | 100 |
46.10~58.20 | 100 | 0 | 0 |
氨基酸对照品溶液的配制:天冬氨酸、苏氨酸、丝氨酸、谷氨酸、甘氨酸、丙氨酸、胱氨酸、缬氨酸、蛋氨酸、异亮氨酸、亮氨酸、酪氨酸、苯丙氨酸、组氨酸、赖氨酸、精氨酸、脯氨酸等17种氨基酸的混合对照品购至德国sykam公司,临用前稀释至0.2μmol·mL-1。
样品的处理-厌氧管充氮密封水解法:精密称取玳瑁(粉碎,过2号筛)约0.1g置厌氧水解管中,加入6mol·L-1的盐酸10mL,将样品全部浸没,冷冻10min,充高纯氮气2min,勿使液面溅起,移开氮气后立即密封,110±1℃水解22h。取出,放冷,精密量取0.3mL,60℃水浴氮气吹干,再精密加入样品稀释液2.00mL,滤过,取续滤液,即得。
样品含量测定:取3批玳瑁生品,按厌氧管充氮密封水解法制备样品溶液,分别进样,测定样品中17种氨基酸的含量,结果如下表所示。
氨基酸名称 | 含量% | RSD% |
ASP天冬氨酸 | 2.27 | 0.8 |
THR苏氨酸 | 1.27 | 0.8 |
SER丝氨酸 | 4.17 | 0.0 |
GLU谷氨酸 | 4.22 | 1.6 |
PRO脯氨酸 | 8.27 | 0.5 |
GLY甘氨酸 | 11.82 | 0.5 |
ALA丙氨酸 | 1.78 | 0.6 |
CYS胱氨酸 | 5.55 | 0.7 |
VAL缬氨酸 | — | — |
MET蛋氨酸 | 0.16 | 3.0 |
ILE异亮氨酸 | 1.77 | 0.6 |
LEU亮氨酸 | 6.80 | 0.3 |
TYR酪氨酸 | 14.23 | 1.2 |
PHE苯丙氨酸 | 2.71 | 2.1 |
HIS组氨酸 | 3.39 | 2.1 |
LYS赖氨酸 | 0.84 | 0.6 |
ARG精氨酸 | 5.44 | 0.4 |
玳瑁经厌氧酸水解后测得氨基酸含量较高,总量不少于75%,其中酪氨酸、甘氨酸、脯氨酸、亮氨酸、胱氨酸、精氨酸等含量均大于5.00%,谷氨酸、丝氨酸、组氨酸、苯丙氨酸、天冬氨酸含量也大于2.00%,赖氨酸及蛋氨酸含量较少,缬氨酸未检出。
实施例3玳瑁糕的制备玳瑁胶100g,冰糖100g,核桃肉100g,桂圆肉30g,枸杞30g,黑芝麻100g,红枣100g,,熟莲子30g,黄酒200ml。冰糖置锅中加入黄酒煮至溶化,加入玳瑁胶烊化后,再依次加入核桃肉、桂圆肉、黑芝麻、红枣、莲子,文火熬制1~2小时,停止加热,倒入事先涂抹油脂的搪瓷盘中,放冷,切片。可用于改善失眠多梦不寐等症状。
以上实施例可以更详细说明本发明,但不以任何形式限制本发明。
Claims (5)
1.一种醋制玳瑁,其特征工艺如下:大小分档的玳瑁药材经砂烫后,河砂使用量是药材量的2至3倍,温度100~180℃;醋淬,醋的使用量浸没药材为度,醋浸时间5至10分钟,干燥制得。
2.根据权利要求1,醋制玳瑁在清热解毒、镇心安神功效上的应用,适用于热病神昏、谵语惊狂、惊风抽搐、痈肿疮毒、斑疹症。
3.一种玳瑁胶的制备,其工艺特征如下:玳瑁药材加水,温度100~110℃,煎煮5~24小时,过滤,滤液加明矾0%~0.1%,搅拌均匀,静置,滤取胶液,浓缩,再依次加入1%~5%的豆油,5%~10%的冰糖粉,5%~10%的黄酒,搅拌均匀,继续浓缩至胶液有气泡鼓起,挑起成片状或线状坠落,停止加热,趁热倒入事先涂抹植物油的瓷盘中,自然冷凝24~48个小时至成固体胶块,取出,切片,得玳瑁胶。
4.根据权利要求3,玳瑁胶在中医药学上的应用,具有清热解毒、镇心安神的功效,可用于高热神昏、谵语惊狂、惊风抽搐、痈肿疮毒、斑疹症。
5.根据权利要求3,玳瑁胶在保健品上的应用,玳瑁胶及含有玳瑁胶的糕点、糖果、饮品、保健品可以用于改善、辅助改善心神不宁引起的失眠、多梦、不寐症状。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610199235.7A CN105726574A (zh) | 2016-04-02 | 2016-04-02 | 玳瑁胶的制备及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610199235.7A CN105726574A (zh) | 2016-04-02 | 2016-04-02 | 玳瑁胶的制备及应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105726574A true CN105726574A (zh) | 2016-07-06 |
Family
ID=56252653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610199235.7A Pending CN105726574A (zh) | 2016-04-02 | 2016-04-02 | 玳瑁胶的制备及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105726574A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106722258A (zh) * | 2016-11-18 | 2017-05-31 | 山东海葵生物科技有限公司 | 一种虾青素阿胶糕及其制备方法 |
CN109652565A (zh) * | 2019-02-13 | 2019-04-19 | 海南热带海洋学院 | 一种鉴别绿海龟和玳瑁制品的扩增引物及其应用和鉴别方法 |
-
2016
- 2016-04-02 CN CN201610199235.7A patent/CN105726574A/zh active Pending
Non-Patent Citations (3)
Title |
---|
傅超美等: "《中药药剂学》", 31 August 2014, 中国医药科技出版社 * |
南京中医药大学: "《中药大辞典》", 31 March 2006, 上海科学技术出版社 * |
张春凤: "《中药炮制学》", 31 August 2015, 中国医药科技出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106722258A (zh) * | 2016-11-18 | 2017-05-31 | 山东海葵生物科技有限公司 | 一种虾青素阿胶糕及其制备方法 |
CN109652565A (zh) * | 2019-02-13 | 2019-04-19 | 海南热带海洋学院 | 一种鉴别绿海龟和玳瑁制品的扩增引物及其应用和鉴别方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013100105A1 (ja) | メイラード反応阻害剤 | |
JP2003192605A (ja) | リパーゼ阻害剤 | |
CN104000757A (zh) | 一种皮肤外用制剂及其应用 | |
JP2008056572A (ja) | ジンゲロール含有水溶性組成物、該ジンゲロール含有水溶性組成物の製造方法、及び該ジンゲロール含有水溶性組成物を含有する飲食品、化粧品、医薬品 | |
CN105726574A (zh) | 玳瑁胶的制备及应用 | |
CN100584308C (zh) | 一种纯中药美容面膜 | |
JP6527715B2 (ja) | 黒生姜含有組成物 | |
CN103845562A (zh) | 一种治疗跌打损伤的药物组合物 | |
CN106722258A (zh) | 一种虾青素阿胶糕及其制备方法 | |
JP5313064B2 (ja) | 中性脂肪蓄積促進剤、豊胸剤 | |
JP2015110536A (ja) | 疲労改善組成物 | |
KR20030079075A (ko) | 탈모방지 및 발모촉진 효능을 지닌 조성물 및 그 이용 방법 | |
CN107496725A (zh) | 以湖北海棠和竹取物为有效成分的功能食品组合物及用途 | |
JP2005304369A (ja) | 高麗人参及び霊芝又はこれらの抽出物を含有する健康補助食品 | |
TWI235663B (en) | Oral liquid preparations | |
KR101416673B1 (ko) | 초음파 처리를 이용한 인삼 프로사포게닌 고농도 함유 인삼 화뢰 제제 및 이의 제조방법 | |
KR20170142725A (ko) | 실크 단백질 및 하수오 추출물을 유효성분으로 포함하는 갱년기 증상 완화용 조성물 | |
JP2004173589A (ja) | 花粉症を改善または予防する食品 | |
TW200528123A (en) | Lipase inhibitor | |
JP2019034902A (ja) | 組成物 | |
WO2009135353A1 (zh) | 梅树提取物的用途 | |
CN101816708A (zh) | 治疗风湿病的中药组合物及其制备方法 | |
CN1216142C (zh) | 一种养生酒及其制备方法 | |
CN104306553B (zh) | 一种降血脂的食品、保健品或药物组合物 | |
TWI377948B (en) | A manufacture method of a plant extraction for reducing blood sugar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160706 |